These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6173446)

  • 1. Expression of HLA-DR antigen in skin from patients with psoriasis.
    Morhenn VB; Abel EA; Mahrle G
    J Invest Dermatol; 1982 Feb; 78(2):165-8. PubMed ID: 6173446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Langerhans cells in skin from patients with psoriasis: quantitative and qualitative study of T6 and HLA-DR antigen-expressing cells and changes with aromatic retinoid administration.
    Haftek M; Faure M; Schmitt D; Thivolet J
    J Invest Dermatol; 1983 Jul; 81(1):10-4. PubMed ID: 6345681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal T lymphocytes and HLA-DR expression in psoriasis.
    Baker BS; Swain AF; Fry L; Valdimarsson H
    Br J Dermatol; 1984 May; 110(5):555-64. PubMed ID: 6232938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reappraisal of in situ immunophenotypic analysis of psoriasis skin: interaction of activated HLA-DR+ immunocompetent cells and endothelial cells is a major feature of psoriatic lesions.
    de Boer OJ; van der Loos CM; Hamerlinck F; Bos JD; Das PK
    Arch Dermatol Res; 1994; 286(2):87-96. PubMed ID: 7512323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-DR expression on keratinocytes is a common feature of diseased skin.
    Auböck J; Romani N; Grubauer G; Fritsch P
    Br J Dermatol; 1986 Apr; 114(4):465-72. PubMed ID: 2421756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fc gamma-receptors and HLA-DR antigens on endothelial cells in psoriatic skin lesions.
    Bjerke JR; Livden JK; Matre R
    Acta Derm Venereol; 1988; 68(4):306-11. PubMed ID: 2459875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of class II HLA antigens (HLA-DR, DQW1, DQW3) in normal skin and cutaneous pathology].
    Gomes M; Schmitt D; Dezutter-Dambuyant C; Capra JD; Thivolet J
    Pathol Biol (Paris); 1986 Mar; 34(3):157-64. PubMed ID: 3517784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of HLA-DR molecules by keratinocytes, and presence of Langerhans cells in the dermal infiltrate of active psoriatic plaques.
    Gottlieb AB; Lifshitz B; Fu SM; Staiano-Coico L; Wang CY; Carter DM
    J Exp Med; 1986 Oct; 164(4):1013-28. PubMed ID: 2428913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demonstration of Ia-like antigens on T lymphocytes in lesions of psoriasis, lichen planus and discoid lupus erythematosus.
    Bjerke JR; Matre R
    Acta Derm Venereol; 1983; 63(2):103-7. PubMed ID: 6189323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermal T lymphocytes and dendritic cells in chronic plaque psoriasis: the effects of PUVA treatment.
    Baker BS; Swain AF; Griffiths CE; Leonard JN; Fry L; Valdimarsson H
    Clin Exp Immunol; 1985 Sep; 61(3):526-34. PubMed ID: 3878241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of epidermal Langerhans' cells and endothelial cell HLA-DR antigens in the skin in progressive systemic sclerosis.
    Andrews BS; Friou GJ; Barr RJ; Mirick GR; Berman M; Sandborg C; Ross PA
    J Rheumatol; 1986 Apr; 13(2):341-8. PubMed ID: 2941574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In cutaneous T-cell lymphoma, class II MHC molecules on CD1+ antigen-presenting cells are upregulated in involved compared with uninvolved epidermis.
    Hansen ER; Bang B; Larsen JK; Vejlsgaard GL; Baadsgaard O
    Br J Dermatol; 1994 Dec; 131(6):780-8. PubMed ID: 7531998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell surface expression of invariant gamma-chain of class II histocompatibility antigens in human skin.
    Claesson-Welsh L; Scheynius A; Tjernlund U; Peterson PA
    J Immunol; 1986 Jan; 136(2):484-90. PubMed ID: 2416807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Increase of circulating HLA DR+ T lymphocytes in psoriasis].
    Paciel J; Vignale RA; Bruno J; Vázquez G; De Anda G
    Med Cutan Ibero Lat Am; 1984; 12(6):497-500. PubMed ID: 6397671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of cyclosporine A inhibition of antigen-presenting activity in uninvolved and lesional psoriatic epidermis.
    Cooper KD; Baadsgaard O; Ellis CN; Duell E; Voorhees JJ
    J Invest Dermatol; 1990 May; 94(5):649-56. PubMed ID: 2324521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of factor XIIIa positive dermal dendritic cells in normal and inflamed skin.
    Cerio R; Griffiths CE; Cooper KD; Nickoloff BJ; Headington JT
    Br J Dermatol; 1989 Oct; 121(4):421-31. PubMed ID: 2576222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of HLA-DR expression by human epidermal cells after growth in culture.
    Hefton JM; Amberson JB; Biozes DG; Weksler ME
    J Invest Dermatol; 1984 Jul; 83(1):48-50. PubMed ID: 6376639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histocompatibility antigens in psoriasis, psoriatic arthropathy, and ankylosing spondylitis.
    Armstrong RD; Panayi GS; Welsh KI
    Ann Rheum Dis; 1983 Apr; 42(2):142-6. PubMed ID: 6573872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psoriatic epidermal cells demonstrate increased numbers and function of non-Langerhans antigen-presenting cells.
    Baadsgaard O; Gupta AK; Taylor RS; Ellis CN; Voorhees JJ; Cooper KD
    J Invest Dermatol; 1989 Feb; 92(2):190-5. PubMed ID: 2645367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human bone marrow cells positive for terminal deoxynucleotidyl transferase (TdT), HLA-DR, and a T cell marker may represent prothymocytes.
    van Dongen JJ; Hooijkaas H; Comans-Bitter M; Hählen K; de Klein A; van Zanen GE; van't Veer MB; Abels J; Benner R
    J Immunol; 1985 Nov; 135(5):3144-50. PubMed ID: 2413114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.